The new and updated templates support Emergency Use Authorization (EUA) for IVDs intended for the diagnosis and/or treatment of COVID-19.
Nearly 100 low- and moderate-risk medical devices may soon be exempt from 510(k) premarket notification requirements in the US, according to a new FDA notice.
What pharmaceutical, medical device and other manufacturers should consider as vaccine cold chain processes evolve.
Watch our videos to learn more about the topics that are important to you.
The Vietnamese Ministry of Health published a draft decree meant to consolidate and expand the country's regulatory framework for medical devices.
The European Commission's Expert Panel for IVDs is now accepting submissions from Notified Bodies for consultations on performance evaluations for high-risk IVD devices.
Emergo by UL experts have conducted an initial review and identified the new information about the regulations that medical device manufacturers and importers will need to know.
Chinese regulators issue new IVD classification rules based on CFDA and IMDRF efforts, plus requirements for self-testing and self-inspection for medical device registrants
European Commissioners have announced expert panelists for 12 high-risk medical device and IVD categories ahead of MDR, IVDR dates of application. Learn more at Emergo by UL.
The United Kingdom's medicines and healthcare products regulatory agency, (MHRA) updated its medical device and IVD registration guidance to include a section on IVDs undergoing performance evaluation.